Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
- Disclosed ownership: 8%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 8% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 8% | 11,052,632 | 0 | 11,052,632 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 8% | 11,052,632 | 0 | 11,052,632 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 4% | 5,391,171 | 0 | 5,391,171 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.1% | 4,328,461 | 0 | 4,328,461 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.7% | 999,750 | 0 | 999,750 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0.2% | 333,250 | 0 | 333,250 | /s/ Kevin Tang | Chief Executive Officer |